Literature DB >> 28510339

Pharmacokinetics of Tedizolid in Obese and Nonobese Subjects.

Shawn Flanagan1, Sonia L Minassian2, Julie A Passarell3, Jill Fiedler-Kelly3, Philippe Prokocimer1.   

Abstract

Entities:  

Keywords:  clinical research; infectious diseases; pharmaceutical medicine; pharmacokinetics and drug metabolism; special populations

Mesh：

Substances：

Year:  2017        PMID： 28510339     DOI： 10.1002/jcph.928

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN： 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  6 in total

1.  Tedizolid is a promising antimicrobial option for the treatment of Staphylococcus aureus infections in cystic fibrosis patients.

Authors:  Melanie Roch; Maria Celeste Varela; Agustina Taglialegna; Adriana E Rosato
Journal:  J Antimicrob Chemother       Date:  2020-01-01       Impact factor: 5.790

2.  Pharmacokinetics of Tedizolid in an Obese Patient after Bariatric Surgery.

Authors:  Matthieu Grégoire; Julia Brochard Libois; Denis Waast; Benjamin Gaborit; Marc Dauty; Guillaume Deslandes; Eric Dailly; Sophie Touchais; David Boutoille; Nicolas Grégoire; William Couet
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

Review 3.  Clinical Pharmacokinetics and Pharmacodynamics of Oxazolidinones.

Authors:  Claire Roger; Jason A Roberts; Laurent Muller
Journal:  Clin Pharmacokinet       Date:  2018-05       Impact factor: 6.447

4.  Comparative Assessment of Tedizolid Pharmacokinetics and Tissue Penetration between Diabetic Patients with Wound Infections and Healthy Volunteers via In Vivo Microdialysis.

Authors:  Sean M Stainton; Marguerite L Monogue; Arlinda Baummer-Carr; Ashley K Shepard; James F Nugent; Joseph L Kuti; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

Review 5.  Pharmacokinetics and Pharmacodynamics of Tedizolid.

Authors:  Khalid Iqbal; Aliki Milioudi; Sebastian Georg Wicha
Journal:  Clin Pharmacokinet       Date:  2022-02-07       Impact factor: 6.447

6.  Real-Life Evidence for Tedizolid Phosphate in the Treatment of Cellulitis and Wound Infections: A Case Series.

Authors:  Sergey Shlyapnikov; Arturo Jauregui; Nana N Khachatryan; Asok Kurup; Javier de la Cabada-Bauche; Hoe N Leong; Li Li; Mark H Wilcox
Journal:  Infect Dis Ther       Date:  2018-07-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.